Harmony Biosciences Holdings, Inc. EPS (Earnings per Share) 2019–2025
Harmony Biosciences Holdings, Inc. reported $2.71 of earnings per share for fiscal 2025. That was 8.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +209.3%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $2.71 | +8.0% |
| FY 2024 | $2.51 | +17.8% |
| FY 2023 | $2.13 | -28.3% |
| FY 2022 | $2.97 | +412.1% |
| FY 2021 | $0.58 | +123.4% |
| FY 2020 | $-2.48 | +89.7% |
| FY 2019 | $-24.07 | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HRMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Harmony Biosciences Holdings, Inc. reported $2.71 of earnings per share for fiscal 2025. That was 8.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +209.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s earnings per share?
Harmony Biosciences Holdings, Inc. (HRMY) reported earnings per share of $2.71 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.